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Transgenic mouse linea b s t r a c t
Distinct mutations in the gap junction protein connexin30 (Cx30) can cause the ectodermal dyspla-
sia Clouston syndrome in humans. We have generated a new mouse line expressing the Clouston
syndrome mutation Cx30A88V under the control of the endogenous Cx30 promoter. Our results
show that the mutated Cx30A88V protein is incorporated in gap junctional plaques of the epidermis.
Homozygous Cx30A88V mice reveal hyperproliferative and enlarged sebaceous glands as well as a
mild palmoplantar hyperkeratosis. Additionally, homozygous mutant mice show an altered hearing
proﬁle compared to control mice. We conclude that the Cx30A88V mutation triggers hyperprolifer-
ation in the skin and changes the cochlear homeostasis in mice.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction change of molecules up to a mass of 1.8 kDa [8]. Gap junctionsClouston’s hidrotic ectodermal dysplasia (HED, also called Clou-
ston syndrome, OMIM #129500) is a rare autosomal dominant ge-
netic disorder characterized by alopecia, nail dystrophies and
palmoplantar hyperkeratosis. Some patients develop hyperpig-
mentation of the skin over the large joints [1]. Additionally, senso-
rineural hearing loss has been reported in a few cases [2,3]. The
extent of the symptoms can be highly variable even within the
same family, i.e. the hair loss can be partial or total and can be
manifested at birth or later [4]. Molecular genetic screening of
Clouston syndrome patients revealed that the patients carried an
autosomal dominant mutation in the GJB6 gene, which encodes
the gap junction protein connexin30 (Cx30) [5–7].
Gap junctions are transmembrane channel proteins, which
mediate cell–cell communication. They form conduits in the plas-
ma membrane of two adjacent cells allowing the diffusional ex-are composed of connexin protein subunits. Six connexins build a
hemichannel (connexon), which can interact with a hemichannel
of a contacting cell to form a complete intercellular gap junction
channel [9]. Connexins are members of a multigene family. So
far, 20 different connexin isoforms have been described in mice
and 21 have been found to be expressed in humans [10]. Each
connexin isoform shows a cell type speciﬁc expression and distinct
contribution to channel properties [11].
So far, four different Clouston syndrome-causing human Cx30
mutations have been identiﬁed: Cx30G11R, Cx30A88V, Cx30V37E
and Cx30D50N [5–7]. Moreover, another Cx30 mutation
(Cx30T5M) has been described to lead to hearing impairments in
humans. However, in contrast to the Clouston syndrome associated
mutations, patients harboring the Cx30T5M mutation exhibit no
hair and skin symptoms [12]. Mutations in connexins can alter
the channel properties of gap junctions. Coupling analyses of the
mutations Cx30G11R and Cx30A88V in HeLa cells and in paired
Xenopus oocytes revealed that these mutations do not inﬂuence
the formation of functional intercellular channels, but cause open
hemichannels as indicated by a leakage of ATP into the extracellu-
lar medium [13].
In order to analyse the effects of Cx30A88V in vivo, we inserted
this mutation into the mouse genome. After ubiquitous
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Cx30A88V mutation is expressed under control of the endogenous
Cx30 promoter. Homozygous Cx30A88V mice exhibit several
symptoms of the highly variable Clouston syndrome, for example
a mild hyperkeratosis of the palmoplantar skin and hearing impair-
ment, whereas other characteristics like hair loss and nail defects
are not displayed by this mouse line.
2. Material and methods
The material and methods are summarized. Detailed descrip-
tions of all methods can be found in the Supplemental material.
2.1. Treatment of mice
All experiments were performed with littermates of >87.5% CD-
1 background.
All mice used in this study were kept under standard housing
conditions with a 12 h/12 h dark-light cycle and with food water
ad libitum. All experiments were carried out in agreement with lo-
cal and state regulations for research with animals.
2.2. Histological and immunoﬂuorescence analyses
For histological and immunoﬂuorescence analyses skin biopsies
were taken from the dorsal mid-thoracic region and from the paws.
For histological analyses the skin biopsies were ﬁxed in Bouin’s
solution and embedded in parafﬁn or in 2-Hydroxyethylmethacry-
late (Technovit 7100, Heraeus Kulzer, Wehrheim, Germany). The
5 lm thick sections were stained with haematoxylin/eosin (HE).
For immunoﬂuorescence analyses skin biopsies were frozen in
Tissue-Tek embedding medium (Sakura, Zoeterwonde, The Nether-
lands), ﬁxed in 4% paraformaldehyde and cryosectioned (14 lm).
The following primary antibodies were used: mouse anti-Cx26
(monoclonal, 1:500, Invitrogen, Carlsbad, CA, USA, Cat. No. 13-
8100), rabbit anti-Cx30 (diluted 1:250, Invitrogen, Cat. No. 71-
2200), rabbit anti-keratin1 (diluted 1:500, Covance CRP, Muenster,
Germany, Cat. No. PRB-149P), guinea pig anti-keratin K2e (diluted
1:200, Progen, Heidelberg, Germany, Cat. No. GP-CK2e), mouse
anti-keratin 6 (monoclonal, diluted 1:100, Progen, Cat. Co.
61090), rat anti-Ki67 (monoclonal, diluted 1:50, DakoCytomation,
Glostrup Denmark, Cat. No. M7249), rabbit anti-ß-galactosidase
(diluted 1:500, MP Biomedicals, Santa Ana, CA, USA, Cat. No.
55976). The following secondary antibodies were used: Alexa Fluor
488 goat anti-mouse IgG (diluted 1:1000, Invitrogen, Cat. No. A-
11029, USA), Alexa Fluor 594 goat anti-rabbit IgG (diluted
1:1000, Invitrogen, Cat. No. A-11037, CA, USA), Alexa Fluor 488
goat anti-rat IgG (diluted 1:1000, Invitrogen, Cat. No. A-11006,
USA), Alexa Fluor 488 goat anti-rabbit IgG (diluted 1:1000, Invitro-
gen, Cat. No. A-11008,), Cy2 goat anti-guinea pig IgG (diluted
1:1000, Jackson ImmunoResearch, West Grove, PA, USA).
For Nile Red stainings, cryosections were ﬁxed in 4% parafor-
maldehyde, incubated for 2 h with 5 lg/ml Nile Red solution (Sig-
ma–Aldrich, Cat. No. 72485, St. Louis, MO, USA) and mounted with
Glycergel mounting medium (DakoCytomation, Glostrup,
Denmark).
2.3. Immunoblot analyses
Total protein were extracted from paw skin. Extraction, electro-
phoresis, blotting and detection is described in the supplement.
The following primary antibodies were used: mouse anti-Cx26
(monoclonal, 1:500, Invitrogen, Cat. No. 13-8100), rabbit anti-ker-
atin1 (diluted 1:500, Covance CRP, Cat. No. PRB-149P), guinea pig
anti-keratin K2e (diluted 1:1000, Progen, Cat. No. GP-CK2e) andmouse anti-keratin 6 (monoclonal, diluted 1:100, Progen, Cat. Co.
61090). Loading controls were performed with mouse anti-GAPDH
(diluted 1:10,000, Millipore, Temecula, CA, USA) antibodies.
Horseradish peroxidase-conjugated secondary antibodies (goat
anti-mouse, goat anti-rabbit, goat anti-giunea pig, diluted
1:10000, Jackson ImmunoResearch, West Grove, PA, USA) were
used.
2.4. Hearing analyses
ABR (Auditory Brainstem Responses) were recorded as de-
scribed in [14]. In brief, mice aged 6–9 weeks were anesthetized
with Ketamine/Xylazine i.p. and the difference potential between
subcutaneous electrodes at the mastoid and vertex was recorded
during free-ﬁeld stimulation. ABR threshold was determined with
10 dB precision as the lowest stimulus intensity that evoked a
reproducible response waveform. For DPOAE we used the System
III and the MF1 speaker system (Tucker Davis Technologies) driven
by custom-written Matlab software (Mathworks) to deliver two
continuous primary tones (frequency f2 = 1.2  f1, intensity
l2 = l1-10 dB SPL) and sampled the signal using a MKE-2 micro-
phone (Sennheiser) and sound card (DMX 6Fire, Terratec).
2.5. Statistical analyses
For statistical analyses a two-tailed Student’s t-test or individ-
ual Mann Whitney U tests were used. A P-value < 0.05 was re-
garded as statistically signiﬁcant. Asterisks indicate a P-value of
<0.05 (⁄), <0.01 (⁄⁄) or <0.001 (⁄⁄⁄). Error bars indicate standard er-
ror of the mean (S.E.M.).
3. Results
3.1. Generation of a Cx30A88V mouse line
Cx30A88V mice were generated by targeting the Cx30 locus in
mouse embryonic stem (ES) cells via homologous recombination
(Supplemental Fig. 1A). The conditional targeting vector contains
the wildtype Cx30 sequence ﬂanked by loxP sites and the coding
region of the mutated Cx30A88V. The point mutation in the
Cx30A88V gene, leading to a substitution of an alanine residue
on position 88 by a valine residue, was inserted together with a
ScaI restriction site by mutagenesis PCR. Therefore the ScaI restric-
tion site is not present in the wildtype sequence of Cx30. The
expression of Cx30A88V is linked to the expression of a lacZ repor-
ter gene by an internal ribosomal entry site (IRES) between the
coding region of Cx30A88V and a lacZ gene. The lacZ gene is coding
for ß-galactosidase which, due to a nuclear localization signal
(NLS), is transported to the nucleus and can be used to monitor
the Cx30A88V expression in vivo. For selection of homologously
recombined ES-cells, the vector includes cDNA coding for neomy-
cin resistance, which is ﬂanked by frt-sites.
HM1 ES-cells were transfected with the conditional Cx30A88V
vector. Five out of 800 clones were positive (veriﬁed by PCR and
Southern blot analyses, data not shown) and could be used for
blastocyst injections. The heterozygous Cx30 +/ﬂoxA88V chimeras
were mated with Flp-recombinase expressing mice to delete the
neomycin resistance cDNA (Supplemental Fig. 1B) and with phos-
phoglycerate kinase (pgk)- cre recombinase expressing mice for
ubiquitous deletion of the wildtype Cx30 sequence (Supplemental
Fig. 1C). Cx30A88V mice were genotyped by PCR analyses (Supple-
mental Fig. 1D). To verify the presence of the mutated Cx30A88V
sequence a PCR reaction amplifying the coding region of Cx30wt
and Cx30A88V was performed, followed by a ScaI restriction (Sup-
plemental Fig. 1E). The different genotypes of transgenic Cx30A88V
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tal Fig. 1F).
The heterozygous Cx30+/A88V mice were backcrossed to a CD-
1 background. All mice used for analyses (wildtype, heterozygous
or homozygous Cx30A88V mice) had a CD-1 background of
>87.5%. Breeding of heterozygous Cx30+/A88V mice resulted in
homozygous Cx30A88V/A88V mice which were viable, fertile and
born at the expected Mendelian ratio.
3.2. Cx30A88V is located in gap junction plaques of the plasma
membrane
In order to investigate the localization of the Cx30A88V protein,
immunoﬂuorescence stainings on paw sections using antibodies
against Cx26 (Fig. 1A and B) and Cx30 (Fig. 1C and D) were per-
formed. In the thick palmoplantar epidermis Cx26 and Cx30 co-
localize in the membranes of suprabasal keratinocytes (Fig. 1E).
In homozygous Cx30A88V mice, where only the mutatedFig. 1. The Cx30A88V protein forms gap junction plaques in the plasma membrane of the
sole skin sections of wildtype and homozygous Cx30A88V mice show that both conne
epidermis. Both wildtype connexins co-localize (yellow staining in the merged images (E
(detail view in (F)). Nuclei are in blue. Epidermal layers: St.B: stratum basale, St.S: stratCx30A88V is expressed, Cx30A88V co-localizes with Cx26 in the
plasmamembrane (Fig. 1F). No difference in the expression pattern
of Cx30 or Cx30A88V and Cx26 could be observed between wild-
type and homozygous Cx30A88V mice.
Since a recent publication proposes an inhibiting effect of ge-
netic modiﬁcations of the Cx30 gene on the Cx26 gene expression
[15], we analysed a putative impact of the Cx30A88V construct on
the Cx26 gene. Immunoblot analyses of Cx26 of the liver of
Cx30A88V mice were performed showing no alterations of the
Cx26 expression in the liver of transgenic Cx30A88V mice com-
pared to Cx30 wildtype littermates (Supplemental Fig. 2). There-
fore, we conclude that the Cx30A88V construct does not affect
the expression of the Cx26 gene locus.
3.3. Hyperproliferation of hairfollicle associated sebaceous glands
Homozygous Cx30A88V mice exhibited greasy fur compared to
wildtype littermates (Fig. 2A). This phenotype could be alreadyepidermis. Immunostainings of Cx26 in green (A and B) and Cx30 in red (C and D) in
xins are expressed in the stratum spinosum and stratum granulosum of the thick
and F)). The mutated Cx30A88V also co-localizes with Cx26 in the plasma membrane
um spinosum, StG: stratum granulosum, St.C: stratum corneum. Scale bars: 20 lm.
Fig. 2. Hyperproliferation of hair follicle associated sebaceous glands (SG). The fur of homozygous Cx30A88V mice (A, upper right mouse) appears greasy compared to
wildtype littermates (A, lower left mouse). Hematoxylin and eosin (HE) staining of back skin reveals a strong enlargement of hair follicle associated sebaceous glands (SG) (B
and C, arrows). ß-galactosidase reporter staining shows that Cx30A88V is expressed in transit amplifying cells of sebaceous glands (D). No cross-reaction of the ß-
galactosidase antibodies with the wildtype control section was found (data not shown). The transit amplifying cells of the SG are hyperproliferative in homozygous Cx30A88V
mice, as indicated by Ki67 immunoﬂuorescence signals in green (E and F). Nile red staining detects lipid ﬁlled sebocytes (G and H). Counting of Nile red positive cells reveals
that the SG of homozygous Cx30A88V mice includes 3.5 more sebocytes than heterozygous or wildtype Cx30A88V littermates (I). Nuclei in blue. SG: sebaceous gland; Scale
bars: 20 lm.
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be used to distinguish homozygous Cx30A88V mice from wildtype
littermates, without exception. No age-dependent development of
this phenotype could be observed. The oldest mice which were
analysed were 12 months of age. No other abnormalities of the hair
follicle organisation or number of hair follicles could be seen. Fur-
thermore, no alterations in the frequencies of hair types were ob-
served (Supplement Fig. 3). Heterozygous Cx30+/A88V did not
show fur abnormalities. Sections and HE stainings of dorsal skin re-
vealed a strong enlargement of hair follicle associated sebaceous
glands (SG) in homozygous Cx30A88V mice (Fig. 2C) compared
to wildtype littermates (Fig. 2B). Immunoﬂuorescence analyses
using antibodies against the NLS-ß-galactosidase reporter protein
indicated that Cx30A88V is expressed in the transit amplifying cell
layer of the sebaceous glands and in the outer root sheath of thehair follicle (Fig. 2D). Immunoﬂuorescence staining of the prolifer-
ation marker Ki67 revealed that the transit amplifying cells of the
sebaceous glands are hyperproliferative in homozygous Cx30A88V
mice (Fig. 2E and F). To quantify the number of sebocytes per seba-
ceous gland, back skin sections were stained with the ﬂuorescent
lipid dye Nile red (Fig. 2G and H) and the number of sebocytes
per sebaceous gland were counted. The number of sebocytes in
homozygous Cx30A88V mice was elevated by a factor of 3.5
(Fig. 2I).
To investigate if other sebaceous glands are affected, which are
not associated with hair follicles, cryosections of meibomian
glands were perfomed. Meibomian glands are located at the inner
rim of the eyelids and are not connected to hair follicles. ß-Gal and
Ki67 stainings of meibomian gland sections revealed that
Cx30A88V is also expressed at the proliferative layer of the glands,
Fig. 3. Mild hyperkeratosis of palmoplantar epidermis of Cx30A88V mice. Immunostainings of ß-galactosidase reporter protein in green (A and D) and proliferation marker
Ki67 in red (B and E) of wildtype and homozygous Cx30A88V mice. (G–L) Quantitative immunoblot analyses of keratin 1, keratin 6 and keratin 2e in paw epidermis (J–L)
Statistical evaluation of protein amounts reveals a signiﬁcant increase of keratin 1 (J), keratin 6 (K) and keratin 2e (L) protein level in homozygous Cx30A88V mice compared
to wildtype. The keratin 1 and keratin 2e expression of heterozygous Cx30+/A88V mice seems to be elevated compared to wildtype, but does not reach statistical signiﬁcance.
n = 4 for Keratin 1 and Keratin 2e, n = 6 for Keratin 6.
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mian glands in homozygous mice (Supplemental Fig. 4). This indi-
cates that the hyperproliferation of sebaceous glands is restricted
to those associated with the hair follicle.3.4. Mild hyperkeratosis of palmoplantar epidermis
Morphological analyses with ß-Gal and Ki67 stainings of paw
cryosections showed that some parts of the palmoplantar
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and hyperproliferative compared to wildtype mice (Fig. 3A–F),
but no obvious continuous hyperplasia of the epidermis could be
observed by microscopy. However, quantitative keratin expression
analyses of paw skin revealed a mild hyperkeratosis in homozy-
gous Cx30A88V mice. Keratin 1 is expressed in all suprabasal lay-
ers (Supplemental Fig. 5A–C, in red) and used as a general marker
for differentiation. Keratin 6 is weakly expressed during very late
differentiation in the upper stratum granulosum (Supplemental
Fig. 5A–C in green). Keratin 6 has been described to be upregulated
in hyperproliferative skin [16]. Keratin K2e is expressed in the
upper stratum spinosum and stratum granulosum (Supplemental
Fig. 5D–F) and has been associated with hyperkeratotic epidermis
[17]. Immunoblot analyses with antibodies against keratin 1, kera-
tin 6 and keratin 2e revealed that the protein levels of all three ker-
atins are signiﬁcantly elevated in paw skin samples of homozygous
Cx30A88V mice (Fig. 3J–L). In heterozygous mice there is also a
tendency for higher keratin 1 and keratin 2e expression compared
to wildtype mice, without reaching signiﬁcance.
3.5. Impaired hearing function in Cx30A88V mice
Hearing thresholds were assessed by recordings of Auditory
Brainstem Responses (ABR) evoked by tone burst and click stimuli.
ABR wave forms in Cx30A88V mice had normal latencies and
amplitudes (Fig. 4A). Compared to wildtype and heterozygousFig. 4. Hearing function in Cx30A88Vmice (A) Grand averages of ABR waveforms in
response to 80 dB clicks from wildtype (black, n = 9–10), heterozygous (grey, n = 8)
and homozygous (red, n = 9) Cx30A88V mice. (B) Homozygous Cx30A88V mice
showed signiﬁcant low-frequency hearing impairment as measured by ABR
thresholds. In contrast, high-frequency thresholds were signiﬁcantly lower than
in wildtype and heterozygous control animals. Thresholds for 12 kHz tone bursts
and clicks were unchanged.mice, homozygous Cx30A88V mice showed signiﬁcantly elevated
ABR thresholds in response to low-frequency tone bursts
(Fig. 4B). In contrast, high-frequency ABR thresholds and DPOAE
(Distortion Product Otoacoustic Emissions, Supplemental Fig. 6)
amplitudes were improved in homozygous Cx30A88V mice com-
pared to wildtype and heterozygous controls.
4. Discussion
In this study we have generated and characterized a new trans-
genic mouse line expressing the human Clouston syndrome
Cx30A88V mutation under the control of the endogenous Cx30
promoter.
Previously published cell culture experiments indicated a cyto-
plasmatic localization of the mutated Cx30A88V protein and re-
vealed an improvement of trafﬁcking when co-expressed with
wildtype Cx30 [13,18]. A recent publication shows that the traf-
ﬁcking of Cx30A88V could not be rescued in transfected cells, nei-
ther by co-expressing wildtype Cx30 nor by co-transfection of
wildtype Cx26. However, a part of the overexpressed Cx30A88V
protein was always integrated into the plasma membrane [19].
Our immunoﬂuorescence analyses of homozygous Cx30A88V mice
conﬁrm that the Cx30A88V protein can be integrated into plasma
membranes of the keratinocytes (Fig. 1F). Apparently, under
endogenous regulation the Cx30A88V protein can be incorporated
in plaques of the plasma membranes without additional accumula-
tion in the cytoplasm, which could be an effect of the overexpres-
sion system used in the cell culture studies [13,18,19].
Homozygous mice show an enlargement of hair follicle associ-
ated sebaceous glands, accompanied by hyperproliferation of the
Cx30A88V expressing, Ki67 positive transit-amplifying cells of the
sebaceousglands (Fig. 2). Additionally, homozygousCx30A88Vmice
develop a mild palmoplantar hyperkeratosis, indicated by a higher
expression of keratin 1, keratin 6, and keratin 2e proteins (3). Chan-
nel function analyses of a previous study revealed that channels
composed of Cx30A88V show normal gap junctional coupling, but
a gain-of-function ‘leakage’ of hemichannels, leading to anenhanced
ATP-release into the extracellularmedium[13]. Several studies indi-
cate that this kindof hemichannel activity canpromoteproliferation
[20,21]. It has been suggested that Cx45 hemichannels, which are
expressed in the transit-amplifying cells of the subventricular zone
of the brain, stimulate proliferation by releasing ATP. The authors
propose amodel involving the binding of released ATP to P2X recep-
tors, which leads to Ca2+ release and modulation of cell cycle re-en-
try via ERK1/2 and cyclin D [22]. Of note, a recent publication
showed that air-stimulated ATP release in keratinocytes can be
blocked by hemichannel inhibitors and therefore indicates that
connexin hemichannels are involved in ATP release from keratino-
cytes [23].
The molecular basis for the observed hyperproliferation in the
Cx30A88V mouse line and the palmoplantar hyperkeratinization
of Clouston syndrome patients may be similar to the mechanisms
suggested for Cx45 hemichannels in the subventricular zone of the
brain [22]. For example, an enhanced ATP release by ‘leaky’
Cx30A88V hemichannels could lead to the activation of Ca2+ depen-
dent kinases via binding to Ca2+channels. This could generally alter
gene expression or lead to cell cycle re-entry respectively. Interest-
ingly, the hyperproliferation of sebaceous glands observed in the
Cx30A88Vmice (Fig. 2) occurs only in hair follicle-associated glands.
Free sebaceous glands like the meibomian glands do express
Cx30A88V in a proliferative layer, but are not enlarged (Supplemen-
tal Fig. 4). This may indicate that the enhanced Cx30A88V hemi-
channel activity only leads to hyperproliferation of sebaceous
glands, if the sebaceous glands are part of the pilo-sebaceous unit
and therefore in an environment of Cx30A88V expressing outer root
shaft cells of the hair follicle.
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drome were reported to suffer from hearing loss [2,3], hearing
analyes were performed with the Cx30A88V mouse line. Homozy-
gous Cx30A88V mice showed impaired low-frequency hearing,
consistent with endolymphatic hydrops due to changes in endo-
lymph composition. The unusual ﬁnding of improved high-fre-
quency thresholds in the mutants may easily remain undetected
in a clinical setting. Enlarged DPOAE amplitudes conﬁrm enhanced
cochlear ampliﬁcation in the high-frequency region. Future studies
are required to understand whether this reﬂects a change in co-
chlear micromechanics or a protection from age-or noise-depen-
dent hearing loss due to changes in cochlear homeostasis or in
purinergic signaling due to altered gap junction permeability [24].
Taken together, the Cx30A88V mouse line represents some as-
pects of the human Clouston syndrome and can thus be used to
further investigate the molecular mechanism of this disease, espe-
cially regarding hyperproliferation and hearing loss. However,
clear phenotypic abnormalities occur only in homozygous
Cx30A88V mice, although the Clouston syndrome is dominant in
humans. Therefore, a high expression level of the Cx30A88V mu-
tated protein seems to be required to cause a Clouston-like pheno-
type in mice. In autosomal dominant diseases the severity of the
symptoms can be variable depending on varying expression ratios
of wildtype to mutated protein [25]. Possibly, patients suffering
from more severe symptoms express more mutated Cx30A88V
than wildtype Cx30 protein. This hypothesis could explain the var-
iability of symptoms and severity in Clouston syndrome. One study
shows that patients who were originally diagnosed with Pachyo-
nychia congenital carried the Clouston syndrome associated muta-
tions Cx30G11R and Cx30A88V [26].
Clear differences between the Cx30A88V mouse line and
Cx30A88V patients were observed regarding the fur phenotype,
that is characterized by sebaceous hyperplasia but not by hair loss,
a typical symptom of the human Clouston syndrome. These dissim-
ilarities in mouse and human could be due to the fact that the fur of
mice shows some general structural differences, e.g. the difference
in hair types or the shorter duration of the growth phase compared
to human hair. However, sebaceous gland hyperplasia could also
be a new aspect of the human Clouston syndrome, which should
be kept in mind in future clinical screenings.
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